Literature DB >> 21371239

Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women.

P Izurieta, T N Kakuda, C Feys, J Witek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21371239     DOI： 10.1111/j.1468-1293.2010.00874.x

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  8 in total

1.  The Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 Infection.

Authors:  Jason J Schafer; Saranyu Ravi; Evelyn V Rowland; Germin Shenoda; Nicholas Leon
Journal:  P T       Date:  2011-06

2.  Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

Authors:  Gail F Shust; Jennifer Jao; Gabriela Rodriguez-Caprio; Roberto Posada; Katherine T Chen; Amelia Averitt; Rhoda S Sperling
Journal:  J Pediatric Infect Dis Soc       Date:  2013-04-12       Impact factor: 3.164

Review 3.  Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children.

Authors:  Martina Penazzato; Carlo Giaquinto
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

4.  Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.

Authors:  Tim R Cressey; Alice Stek; Edmund Capparelli; Chureeratana Bowonwatanuwong; Sinart Prommas; Pannee Sirivatanapa; Prapap Yuthavisuthi; Chanon Neungton; Yanling Huo; Elizabeth Smith; Brookie M Best; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

Review 5.  Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection.

Authors:  Jamie D Croxtall
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 6.  Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.

Authors:  Shelley A McCormack; Brookie M Best
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

Review 7.  Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

Authors:  Kajal Buckoreelall; Tim R Cressey; Jennifer R King
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 5.577

8.  Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.

Authors:  Nikki Mulligan; Stein Schalkwijk; Brookie M Best; Angela Colbers; Jiajia Wang; Edmund V Capparelli; José Moltó; Alice M Stek; Graham Taylor; Elizabeth Smith; Carmen Hidalgo Tenorio; Nahida Chakhtoura; Marjo van Kasteren; Courtney V Fletcher; Mark Mirochnick; David Burger
Journal:  Front Pharmacol       Date:  2016-08-04       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.